Stocktoria
GoodRx Holdings, Inc. GDRX
Nasdaq · XNAS · stock · Services-Computer Processing & Data Preparation · website · IPO 2020-09-23
GoodRx Holdings, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 11.0% | 8.3% | -3.6% | 0.2% | 1.8% |
| Net margin | 3.8% | 2.1% | -1.2% | -4.3% | -3.4% |
| FCF margin | 20.6% | 23.1% | 18.3% | 18.6% | 23.4% |
| Return on assets | 2.2% | 1.2% | -0.6% | -2.0% | -1.6% |
| Return on equity | 4.9% | 2.3% | -1.2% | -4.0% | -3.0% |
| Debt / equity | 0.80× | 0.69× | 0.85× | 0.82× | 0.81× |
| Current ratio | 2.61 | 5.32 | 7.12 | 12.05 | 13.42 |
| Revenue growth | 0.6% | 5.6% | -2.1% | 2.8% | 35.4% |
Source: SEC EDGAR filings · CIK 0001809519 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.